
|Videos|December 26, 2016
Access to PCSK9 Inhibitors Remains a Challenge
Author(s)Lauren Santye, Assistant Editor
Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses challenges in gaining access to cholesterol-lowering PCSK9 inhibitors.
Advertisement
Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses challenges in gaining access to cholesterol-lowering PCSK9 inhibitors.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
2
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
3
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
4
Medetomidine: The Demon in the Illicit Fentanyl Supply
5